Mid-sized pharmaceutical firm uses PAS-X Track & Trace on two of its packaging lines in Hamburg to comply with anti-counterfeiting requirements.
Based in Hamburg, Germany, Desitin Arzneimittle GMBH is a pharmaceutical firm that focuses on treating epilepsy and Parkinson’s disease. Its portfolio also includes products that address psychiatric diseases, Huntington’s disease, amyotrophic lateral sclerosis or Dravet Syndrome.
Recently, the mid-sized manufacturer implemented Werum’s PAS-X Track & Trace serialization and aggregation offering at its Hamburg plant. Desitin required a lean, powerful and easy-to-implement track-and-trace solution to comply with the anti-counterfeiting requirements of its various international target markets, which include all EU countries.
Companies in this article
